Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level
In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC
NCI Programs: BSA Approves Formation Of Two Grant Programs:
Molecular target Drug Discovery Grants; Unanimously Approved
Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote
DO RFAs cut Into R01 Grant Pool? Board Asks
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?